Evidence map›Paper›PMID 33971225›Full record

ArticleJournal of hepatology2021

HCV detection is possible during SARS CoV-2 testing; and throughout COVID-19 vaccination?

Javier Crespo, Álvaro Díaz-González, Joaquín Cabezas

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of hepatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Hepatitis C screening during SARS-CoV-2 testing or vaccination. Experience in an area of southern Italy in the province of Salerno.Liver international : official journal of the International Association for the Study of the Liver · 2022
    Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Javier CrespoGastroenterology and Hepatology Department. Marqués de Valdecilla University Hospital, Santander, Spain; Research Institute Valdecilla (IDIVAL), Santander, Spain; School of Medicine, University of Cantabria, Santander, Spain.
Álvaro Díaz-GonzálezGastroenterology and Hepatology Department. Marqués de Valdecilla University Hospital, Santander, Spain; Research Institute Valdecilla (IDIVAL), Santander, Spain.
Joaquín CabezasGastroenterology and Hepatology Department. Marqués de Valdecilla University Hospital, Santander, Spain; Research Institute Valdecilla (IDIVAL), Santander, Spain. Electronic address: joaquin.cabezas@scsalud.es.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Hepatitis CCOVID-19 VaccinesHumansItalySARS-CoV-2VaccinationCOVID-19 VaccinesCOVID-19eliminationHCVmassive testSARS-CoV-2screeningvaccine

Identifiers

PMID33971225
PMCPMC8103740

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.